ANTI-CD20 THERAPY

Clinical trials for ANTI-CD20 THERAPY explained in plain language.

Never miss a new study

Get alerted when new ANTI-CD20 THERAPY trials appear

Sign up with your email to follow new studies for ANTI-CD20 THERAPY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

MS treatment breakthrough? study tests if patients can safely step down powerful drugs

Disease control Not yet recruiting

This study aims to find out if people with stable relapsing-remitting multiple sclerosis (MS) who are over 40 years old can safely switch from a strong, long-term medication (anti-CD20 therapy) to a milder one. Researchers want to see if switching reduces side effects and infecti…

Matched conditions: ANTI-CD20 THERAPY

Phase: PHASE3 • Sponsor: University Hospital, Montpellier • Aim: Disease control

Last updated Mar 31, 2026 12:12 UTC

ANTI-CD20 THERAPY

Get alerted when new ANTI-CD20 THERAPY trials appear

MS treatment breakthrough? study tests if patients can safely step down powerful drugs